Sanofi (SNY) Receivables Refunds (2016 - 2024)
Historic Receivables Refunds for Sanofi (SNY) over the last 11 years, with Q3 2025 value amounting to $581.0 million.
- Sanofi's Receivables Refunds changed N/A to $581.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $581.0 million, marking a year-over-year change of. This contributed to the annual value of $773.7 million for FY2024, which is 8292.0% up from last year.
- Latest data reveals that Sanofi reported Receivables Refunds of $581.0 million as of Q3 2025.
- Sanofi's 5-year Receivables Refunds high stood at $773.7 million for Q4 2024, and its period low was $317.7 million during Q2 2024.
- For the 5-year period, Sanofi's Receivables Refunds averaged around $527.5 million, with its median value being $470.2 million (2025).
- In the last 5 years, Sanofi's Receivables Refunds plummeted by 5139.09% in 2021 and then skyrocketed by 8390.23% in 2024.
- Quarter analysis of 5 years shows Sanofi's Receivables Refunds stood at $700.1 million in 2021, then plummeted by 45.5% to $381.6 million in 2022, then grew by 10.25% to $420.7 million in 2023, then surged by 83.9% to $773.7 million in 2024, then fell by 24.9% to $581.0 million in 2025.
- Its Receivables Refunds was $581.0 million in Q3 2025, compared to $449.4 million in Q2 2025 and $470.2 million in Q1 2025.